Manatt Health’s “Meeting Patient Expectations and Improving Patient Experience During Cancer Treatment” outlines strategies hospital cancer programs can employ to advance patient-centered care and develop long-term relationships with patients.

Scientific advances have led to a significant reduction in cancer mortality and increased survival rates,  yet the number of annual cancer diagnoses continues to grow, with over two million new diagnoses expected in 2024.

The United States occupies a leadership position in clinical advancements, in terms of pharmaceuticals, medical devices, innovative care processes and interventional techniques.

Through clinical trials, eligible patients can receive the latest cutting-edge treatments, which may not yet be available nationwide.

The inclusion of racial and ethnic groups in clinical trials has been a national priority for decades, but progress toward that end has been limited.

Donna O’Brien was featured in Clinical Research as a Care Option’s Autumn newsletter where she outlined what hospitals and health systems are facing when it comes to integrating clinical trials and how they can support diversity in trials. 

Manatt Health National Advisor Donna O’Brien and Managing Director Megan Ingraham were quoted in Home Health Care News on how to achieve high-quality, accessible and affordable cancer treatment through value-based approaches and at-home care.  According to the article, health ...

Manatt Health Partner Rachel Sher and National Advisor Donna O’Brien were quoted in Bloomberg Law on a new law aimed at improving clinical trial diversity by requiring diversity action plans for trials conducted by the Food and Drug Administration (FDA). In the article, Sher explained ...

Donna O'Brien and Rachel Sher to Speak on LinkedIn Live Event with the Decentralized Trials Club on October 11, 2024.

Manatt Health National Advisor Donna O’Brien will speak at the upcoming Clinical Research as a Care Option Conference at the Loews Philadelphia Hotel in Philadelphia, Pennsylvania on September 16th, 2024.

Manatt Health National Advisor Donna O’Brien will speak at a session titled, “Funding Considerations to Increase Representativeness in Clinical Trials” on March 28, from 12:50-1:50 pm EST at the Duke-Margolis Institute for Health Policy upcoming virtual, public convening.

Manatt Health National Advisor Donna O’Brien will speak on October 12th in Washington DC at the National Academies of Sciences, Engineering, and Medicine’s Forum on Drug Discovery, Development, and Translation on the topic of Expanding Clinical Trials into Community Hospitals and Health Systems.